Synthesis of molecularly imprinted polymer as a sorbent for solid phase extraction of citalopram from human serum and urine

  • Majid Abdouss
  • Saman Azodi-Deilami
  • Ebadullah Asadi
  • Zahra Shariatinia


This paper describes a new method for the determination of citalopram in biological fluids using molecularly imprinted solid-phase extraction as the sample cleanup technique combined with high performance liquid chromatography. The molecularly imprinted polymers were prepared using methacrylic acid as functional monomer, ethylene glycol dimethacrylate as crosslinker, chloroform as porogen and citalopram hydrobromide as the template molecule. The novel imprinted polymer was used as a solid-phase extraction sorbent for the extraction of citalopram from human serum and urine. Effective parameters on citalopram retention were studied. The optimal conditions for molecularly imprinted solid-phase extraction consisted of conditioning with 1 mL methanol and 1 mL of deionized water at neutral pH, loading of citalopram sample (50 μg L−1) at pH 9.0, washing using 1 mL acetone and elution with 3 × 1 mL of 10 % (v/v) acetic acid in methanol. The MIP selectivity was evaluated by checking several substances with similar molecular structures to that of citalopram. Results from the HPLC analyses showed that the calibration curve of citalopram using MIP from human serum and urine is linear in the ranges of 1–100 and 2–120 μg L−1 with good precisions (2.5 and 1.5 % for 10.0 μg L−1), and recoveries (between 82–86 and 83–85 %), respectively.


High Performance Liquid Chromatography Tramadol Molecular Imprint Polymer Functional Monomer Imprint Polymer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Greiner C, Hiemke C, Bader W, Haen E. Determination of citalopram and escitalopram together with their active main metabolites desmethyl(es-)citalopram in human serum by column-switching high performance liquid chromatography (HPLC) and spectrophotometric detection. J Chromatogr B. 2007;848:391–4.CrossRefGoogle Scholar
  2. 2.
    Macek J, Ptáček P, Klíma J. Rapid determination of citalopram in human plasma by high-performance liquid chromatography. J Chromatogr B. 2001;755:279–85.CrossRefGoogle Scholar
  3. 3.
    Kristoffersen L, Bugge A, Lundanes E, Slørdal L. Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection. J Chromatogr B. 1999;734:229–46.CrossRefGoogle Scholar
  4. 4.
    Overø KF. Fluorescence assay of citalopram and its metabolites in plasma by scanning densitometry of thin-layer chromatograms. J Chromatogr B. 1981;224:526–31.CrossRefGoogle Scholar
  5. 5.
    Pistos C, Panderi I, Atta-Politou J. Liquid chromatography–positive ion electrospray mass spectrometry method for the quantification of citalopram in human plasma. J Chromatogr B. 2004;810:235–44.Google Scholar
  6. 6.
    Juan H, Zhiling Z, Huande L. Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography–electrospray ionization mass spectrometry (HPLC–MS/ESI). J Chromatogr B. 2005;820:33–9.CrossRefGoogle Scholar
  7. 7.
    Cartiser N, Bévalot F, Le Meur C, Gaillard Y, Malicier D, Hubert N, Guitton J. Gas chromatography–tandem mass spectrometry assay for the quantification of four benzodiazepines and citalopram in eleven postmortem rabbit fluids and tissues, with application to animal and human samples. J Chromatogr B. 2011;879:2909–18.CrossRefGoogle Scholar
  8. 8.
    Berzas Nevado JJ, Villaseñor Llerena MJ, Guiberteau Cabanillas C, Rodríguez Robledo V. Screening of citalopram, fluoxetine and their metabolites in human urine samples by gas chromatography–mass spectrometry: a global robustness/ruggedness study. J Chromatogr A. 2006;1123:130–3.CrossRefGoogle Scholar
  9. 9.
    Reymond Ph, Amey M, Souche A, Lambert S, Konrat H, Eap CB, Baumann P. Determination of plasma levels of citalopram and its demethylated and deaminated metabolites by gas chromatography and gas chromatography–mass spectrometry. J Chromatogr B. 1993;616:221–8.CrossRefGoogle Scholar
  10. 10.
    Bagheri H, Khalilian F, Babanezhad E, Es-haghi A, Rouini MR. Modified solvent microextraction with back extraction combined with liquid chromatography-fluorescence detection for the determination of citalopram in human plasma. Anal Chim Acta. 2008;610:211–6.CrossRefGoogle Scholar
  11. 11.
    Rouini MR, Ardakani YH, Soltani F, Aboul-Enein HY, Foroumadi A. Development and validation of a rapid HPLC method for simultaneous determination of tramadol, and its two main metabolites in human plasma. J Chromatogr B. 2006;830:207.CrossRefGoogle Scholar
  12. 12.
    Gan SH, Ismail R, Wan Adnan WA, Wan Z. Method development and validation of a high-performance liquid chromatographic method for tramadol in human plasma using liquid–liquid extraction. J Chromatogr B. 2002;772:123.CrossRefGoogle Scholar
  13. 13.
    Yeh GC, Sheu MT, Yem CL, Wang YW, Liu CH, Ho HO. High-performance liquid chromatographic method for determination of tramadol in human plasma. J Chromatogr B. 1999;723:247.CrossRefGoogle Scholar
  14. 14.
    Nobilis M, Kopecky J, Kvetinc J, Chladek J, Svobodo Z, Vorisek V, Perlik F, Pour M, Kunes J. High-performance liquid chromatographic determination of tramadol and its O-desmethylated metabolite in blood plasma: application to a bioequivalence study in humans. J Chromatogr A. 2002;949:11.CrossRefGoogle Scholar
  15. 15.
    Kmetec V, Rosker R. HPLC determination of tramadol in human breast milk. J Pharm Biomed Anal. 2003;32:1061.CrossRefGoogle Scholar
  16. 16.
    Campanero MA, Garcia-Quetglas E, Sadaba B, Azanza JR. Simultaneous stereoselective analysis of tramadol and its primary phase I metabolites in plasma by liquid chromatography: application to a pharmacokinetic study in humans. J Chromatogr A. 2004;1031:219.CrossRefGoogle Scholar
  17. 17.
    Huck CW, Bonn GK. Recent developments in polymer-based sorbents for solid-phase extraction. J Chromatogr A. 2000;885:51.CrossRefGoogle Scholar
  18. 18.
    Seo JJ, Kim HY, Chung BC, Hong JK. Simultaneous determination of anabolic steroids and synthetic hormones in meat by freezing-lipid filtration, solid-phase extraction and gas chromatography–mass spectrometry. J Chromatogr A. 2005;1067:303–9.CrossRefGoogle Scholar
  19. 19.
    Long Z, Hong L, Jie J. Determination of β-estradiol residues in fish/shellfish muscle by gas chromatography–mass spectrometry. J Anal Chem. 2007;35:983–7.Google Scholar
  20. 20.
    Jiang T, Zhao L, Chu B, Feng Q, Yan W, Lin JM. Molecularly imprinted solidphase extraction for the selective determination of 17ß-estradiol in fishery samples with high performance liquid chromatography. Talanta. 2009;78:442–7.CrossRefGoogle Scholar
  21. 21.
    Chaitidou S, Kotrotsiou O, Kiparissides C. The synthesis and rebinding properties of [Co(C2H3O2)2(z-histidine)] imprinted polymers prepared by precipitation polymerization. Mater Sci Eng C. 2009;29:1415–21.CrossRefGoogle Scholar
  22. 22.
    Zakaria ND, Yusof NA, Haron J, Abdullah AH. Synthesis and evaluation of a molecularly imprinted polymer for 2,4-dinitrophenol. Int J Mol Sci. 2009;10:354–65.CrossRefGoogle Scholar
  23. 23.
    Dmitrienko SG, Irkha VV, Zolotor YA. Use of molecular imprinted polymers for the separation and preconcentration of organic compounds. J Anal Chem. 2004;59:808–17.CrossRefGoogle Scholar
  24. 24.
    Pichon V, Chapuis-Hugon F. Role of molecularly imprinted polymers for selective determination of environmental pollutants—a review. Anal Chim Acta. 2008;622:48–61.CrossRefGoogle Scholar
  25. 25.
    Beltran A, Caro E, Marcé RM, Cormack PAG, Sherrington DC, Borrull F. Synthesis and application of a carbamazepine-imprinted polymer for solid-phase extraction from urine and wastewater. Anal Chim Acta. 2007;597:6–11.CrossRefGoogle Scholar
  26. 26.
    Qiujin Z, Liping W, Shengfang W, Wasswa J, Xiaohong G, Jian T. Selectivity of molecularly imprinted solid phase extraction for sterol compounds. Food Chem. 2009;113:608–15.CrossRefGoogle Scholar
  27. 27.
    Turiel E, Martín-Esteban A. Molecularly imprinted polymers for sample preparation: a review. Anal Chim Acta. 2010;668:87–99.CrossRefGoogle Scholar
  28. 28.
    Beltrana A, Marcéa RM, Cormackb PAG, Borrull F. Synthesis by precipitation polymerization of molecularly imprinted polymer microspheres for the selective extraction of carbamazepine and oxcarbazepine from human urine. J Chromatogr A. 2009;1216:2248–53.CrossRefGoogle Scholar
  29. 29.
    Yin X, Liu Q, Jiang Y, Luo Y. Development of andrographolide molecularly imprinted polymer for solid-phase extraction. Spectrochim Acta, A. 2011;79:191–6.CrossRefGoogle Scholar
  30. 30.
    Azodi-Deilami S, Abdouss M, Seyedi SR. Synthesis and characterization of molecularly imprinted polymer for controlled release of tramadol. Cent Eur J Chem. 2010;8:687–95.CrossRefGoogle Scholar
  31. 31.
    Azodi-Deilami S, Abdouss M, Javanbakht M. The syntheses and characterization of molecularly imprinted polymer for controlled release of bromhexine. Appl Biochem Biotechnol. 2011;164:133–47.CrossRefGoogle Scholar
  32. 32.
    Abdouss M, Asadi E, Azodi-Deilami S, Beik-mohammadi N, Amir Aslanzadeh S. Development and characterization of molecularly imprinted polymers for controlled release of citalopram. J Mater Sci Mater Med. 2011;22:2273–81.CrossRefGoogle Scholar
  33. 33.
    Azodi-Deilami S, Abdouss M, Hasani AR. Preparation and utilization of a molecularly imprinted polymer for solid phase extraction of tramadol. Cent Eur J Chem. 2010;8:861–9.CrossRefGoogle Scholar
  34. 34.
    Moffat AC. Clarkes analysis of drugs and poisons in pharmaceuticals. vol. 2. 3rd ed. London: Pharmaceutical Press; 2004.Google Scholar
  35. 35.
    Guyot A, Sherrington DC, Hodge P. Synthesis and separations using functional polymers. New York: Wiley; 1989. p. 1–36.Google Scholar
  36. 36.
    Lloyd L. Rigid macroporous copolymers as stationary phases in high-performance liquid chromatography. J Chromatogr A. 1991;544:201–17.CrossRefGoogle Scholar
  37. 37.
    Rachkov A, Minoura N. Recognition of oxytocin and oxytocinrelated peptides in aqueous media using a molecularly imprinted polymer synthesized by the epitope approach. J Chromatogr A. 2000;889:111–8.CrossRefGoogle Scholar
  38. 38.
    Martin P, Jones GR, Stringer F, Wilson ID. Comparison of normal and reversed-phase solid phase extraction methods for extraction of b-blockers from plasma using molecularly imprinted polymers. J Anal. 2003;128:345–50.CrossRefGoogle Scholar
  39. 39.
    Shea KJ, Spivak DA, Sellergren B. Imprinted polymer membranes for the selective transport of targeted neutral molecules. J Am Chem Soc. 1993;115:3368–9.CrossRefGoogle Scholar
  40. 40.
    Mullet WM, Walles M, Levsen K, Borlak J, Pawliszyn J. Multidimensional on-line sample preparation of verapamil and its metabolites by a molecularly imprinted polymer coupled to liquid chromatography–mass spectrometry. J Chromatogr B. 2004;801:297–306.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Majid Abdouss
    • 1
  • Saman Azodi-Deilami
    • 1
  • Ebadullah Asadi
    • 1
  • Zahra Shariatinia
    • 1
  1. 1.Department of ChemistryAmirkabir University of TechnologyTehranIran

Personalised recommendations